YZC [YANZHOU COAL MINING CO] 6-K: (Original Filing)
[Yanzhou Coal Mining Company Limited Date May 6, 2015 By Zhang Baocai Director and Company Secretary]
YZC [YANZHOU COAL MINING CO] 6-K: Yanzhou Coal Mining Company Limited Date May 6,
[Yanzhou Coal Mining Company Limited Date May 6, 2015 By Zhang Baocai Director and Company Secretary]
CBPO [China Biologic Products] 8-K: (Original Filing)
[FOR RELEASE May 6, 2015 China Biologic Reports Financial Results for the First Quarter of 2015 1Q15 Total Sales Increases 25% to $70.4 Million 1Q15 Non-GAAP Net Income Increases 30.9% to $ 25.0 Million Raises FY15 Total Sales Forecast BEIJING, China – May 6, 2015 – First Quarter 2015 Financial Highlights · Total sales · Gross profit · Income from] []
CBPO [China Biologic Products] 8-K: FOR RELEASE May 6, 2015 China Biologic Reports
[FOR RELEASE May 6, 2015 China Biologic Reports Financial Results for the First Quarter of 2015 1Q15 Total Sales Increases 25% to $70.4 Million 1Q15 Non-GAAP Net Income Increases 30.9% to $ 25.0 Million Raises FY15 Total Sales Forecast BEIJING, China – May 6, 2015 – First Quarter 2015 Financial Highlights · Total sales · Gross profit · Income from] []
CBPO [China Biologic Products] IRANNOTICE: (Original Filing)
[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China May 6, 2015 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the]
CBPO [China Biologic Products] IRANNOTICE: China Biologic Products, Inc. 8th Floor, Jialong International
[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China May 6, 2015 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the]
CBPO [China Biologic Products] 10-Q: (Original Filing)
[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]
CBPO [China Biologic Products] 10-Q:
[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]
